0
Original Research: CRITICAL CARE |

Impact of Nonexacerbated COPD on Mortality in Critically Ill Patients

Alejandro Rodríguez, MD, PhD; Thiago Lisboa, MD; Jorge Solé-Violán, MD, PhD; Federico Gómez, MD; Oriol Roca, MD, PhD; Sandra Trefler, BSc; Joaquim Gea, MD, PhD; Joan R. Masclans, MD, PhD; Jordi Rello, MD, PhD
Author and Funding Information

From the Critical Care Department (Drs Rodríguez and Lisboa and Ms Trefler) and Microbiologic Department (Dr Gómez), Joan XXIII University Hospital, CibeRes Enfermedades Respiratorias, Universidad Rovira i Virgili-IISPV, Tarragona; Critical Care Department (Dr Solé-Violán), Dr Negrín University Hospital, Las Palmas de Gran, Canaria; Critical Care Department (Drs Roca, Masclans, and Rello), Vall d’Hebron University Hospital, VHIR-Universitat Autonoma Barcelona, CibeRes, Barcelona; and Respiratory Department (Dr Gea), Hospital del Mar, IMIM-UPF, CibeRes, Barcelona, Spain.

Correspondence to: Jordi Rello, MD, PhD, Critical Care Department, Vall D’Hebron University Hospital, P Vall D’Hebron 119, 129, 08035 Barcelona, Spain; e-mail: jrello.hj23.ics@gencat.cat


Funding/Support: This work was supported in part by Marató TV3, CibeRes, and AGAUR (2009/SGR/920].

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (http://www.chestpubs.org/site/misc/reprints.xhtml).


© 2011 American College of Chest Physicians


Chest. 2011;139(6):1354-1360. doi:10.1378/chest.10-2439
Text Size: A A A
Published online

Background:  The real contribution of nonexacerbated COPD to mortality has not been studied. The aim of our study was to evaluate the impact of nonexacerbated COPD on mortality in patients requiring mechanical ventilation (MV).

Methods:  This prospective, observational study included critically ill, ventilated patients without evidence of respiratory infection. Patients with COPD comprised the study group. Clinical and demographics variables were recorded. The main end point was ICU mortality.

Results:  Of the 235 patients included, 60 (25.5%) intubated patients had COPD. The remaining 175 (74.5%) comprised the control group. Those with COPD were more often medical patients who were older and had a higher number of comorbidities and a higher APACHE (Acute Physiology and Chronic Health Evaluation) II score than intubated patients without COPD (P < .05). The overall ICU mortality was 26.3% (62/235) and significantly higher in patients with nonexacerbated COPD (36.7% vs 22.9%, P < .05), with an attributable mortality to COPD of 13.8%. Incidence of ventilator-associated pneumonia was not significantly different between patients with nonexacerbated COPD (11.9/1,000 MV days) and without COPD (16.0/1,000 MV days; P = .40). In the multivariate analysis, only COPD (hazard ratio [HR], 2.1; 95% CI, 1.10-3.94), shock at ICU admission (HR, 2.0; 95% CI, 1.01-4.01), and medical condition (HR, 1.7; 95% CI, 1.01-3.18) were independently associated with mortality.

Conclusions:  Intubated patients with nonexacerbated COPD were not exposed to a higher risk of ventilator-associated pneumonia but had a higher rate of mortality.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543